Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Evelo Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 41 | 44 | +3 |
| Shares | 86.1M | 87.0M | +906.1K (+1.1%) |
| Value | $180.0M | $140.1M | −$39.9M (−22.2%) |
New holders (9)
Institutions that held Evelo Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mayo Clinic | 479,242 | $771.6K | 0.41% |
| Trustees of Columbia University in the City of New York | 113,850 | $183.0K | 0.38% |
| 683 Capital Management, LLC | 90,291 | $145.4K | 0.01% |
| Boothbay Fund Management, LLC | 52,699 | $84.8K | 0.00% |
| Man Group plc | 52,637 | $84.7K | 0.00% |
| Shay Capital LLC | 18,511 | $29.8K | 0.02% |
| Balyasny Asset Management LLC | 10,135 | $16.3K | 0.00% |
| Citadel Advisors LLC | 9,952 | $16.0K | 0.00% |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% |
Sold out (6)
Institutions that held Evelo Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ergoteles LLC | 27,429 | $57.0K |
| Occudo Quantitative Strategies LP | 25,346 | $53.0K |
| Schonfeld Strategic Advisors LLC | 19,100 | $40.0K |
| Cresset Asset Management, LLC | 18,366 | $38.0K |
| Group One Trading, L.P. | 11,082 | $23.0K |
| LMR Partners LLP | 10,833 | $23.0K |